205 related articles for article (PubMed ID: 18629632)
21. Inhibitory effect of antagonists of bombesin and growth hormone-releasing hormone on orthotopic and intraosseous growth and invasiveness of PC-3 human prostate cancer in nude mice.
Stangelberger A; Schally AV; Varga JL; Zarandi M; Szepeshazi K; Armatis P; Halmos G
Clin Cancer Res; 2005 Jan; 11(1):49-57. PubMed ID: 15671527
[TBL] [Abstract][Full Text] [Related]
22. Expression of Receptors for Pituitary-Type Growth Hormone-Releasing Hormone (pGHRH-R) in Human Papillary Thyroid Cancer Cells: Effects of GHRH Antagonists on Matrix Metalloproteinase-2.
Catanuto P; Tashiro J; Rick FG; Sanchez P; Solorzano CC; Glassberg MK; Block NL; Lew JI; Elliot SJ; Schally AV
Horm Cancer; 2015 Jun; 6(2-3):100-6. PubMed ID: 25752763
[TBL] [Abstract][Full Text] [Related]
23. Differential expression of GHRH receptor and its splice variant 1 in human normal and malignant mucosa of the oesophagus and colon.
Hohla F; Moder A; Mayrhauser U; Hauser-Kronberger C; Schally AV; Varga JL; Zarandi M; Buchholz S; Huber R; Aigner E; Ritter M; Datz C
Int J Oncol; 2008 Jul; 33(1):137-43. PubMed ID: 18575759
[TBL] [Abstract][Full Text] [Related]
24. Expression of growth hormone-releasing hormone and its receptor splice variants in human prostate cancer.
Halmos G; Schally AV; Czompoly T; Krupa M; Varga JL; Rekasi Z
J Clin Endocrinol Metab; 2002 Oct; 87(10):4707-14. PubMed ID: 12364462
[TBL] [Abstract][Full Text] [Related]
25. Agonists of growth hormone-releasing hormone (GHRH) inhibit human experimental cancers in vivo by down-regulating receptors for GHRH.
Schally AV; Wang H; He J; Cai R; Sha W; Popovics P; Perez R; Vidaurre I; Zhang X
Proc Natl Acad Sci U S A; 2018 Nov; 115(47):12028-12033. PubMed ID: 30373845
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of human androgen-independent PC-3 and DU-145 prostate cancers by antagonists of bombesin and growth hormone releasing hormone is linked to PKC, MAPK and c-jun intracellular signalling.
Stangelberger A; Schally AV; Varga JL; Zarandi M; Cai RZ; Baker B; Hammann BD; Armatis P; Kanashiro CA
Eur J Cancer; 2005 Nov; 41(17):2735-44. PubMed ID: 16291086
[TBL] [Abstract][Full Text] [Related]
27. Expression and possible implication of growth hormone-releasing hormone receptor splice variant 1 in endometriosis.
Fu L; Osuga Y; Yano T; Takemura Y; Morimoto C; Hirota Y; Schally AV; Taketani Y
Fertil Steril; 2009 Jul; 92(1):47-53. PubMed ID: 18684444
[TBL] [Abstract][Full Text] [Related]
28. GHRH antagonists reduce the invasive and metastatic potential of human cancer cell lines in vitro.
Bellyei S; Schally AV; Zarandi M; Varga JL; Vidaurre I; Pozsgai E
Cancer Lett; 2010 Jul; 293(1):31-40. PubMed ID: 20064686
[TBL] [Abstract][Full Text] [Related]
29. GHRH proliferative action on somatotrophs is cell-type specific and dependent on Pit-1/GHF-1 expression.
Solloso A; Barreiro L; Seoane R; Nogueira E; Cañibano C; Alvarez CV; Zalvide J; Diéguez C; Pombo CM
J Cell Physiol; 2008 Apr; 215(1):140-50. PubMed ID: 17941086
[TBL] [Abstract][Full Text] [Related]
30. Expression of a splice variant of the receptor for GHRH in 3T3 fibroblasts activates cell proliferation responses to GHRH analogs.
Kiaris H; Schally AV; Busto R; Halmos G; Artavanis-Tsakonas S; Varga JL
Proc Natl Acad Sci U S A; 2002 Jan; 99(1):196-200. PubMed ID: 11773624
[TBL] [Abstract][Full Text] [Related]
31. Ligand-dependent and -independent effects of splice variant 1 of growth hormone-releasing hormone receptor.
Kiaris H; Chatzistamou I; Schally AV; Halmos G; Varga JL; Koutselini H; Kalofoutis A
Proc Natl Acad Sci U S A; 2003 Aug; 100(16):9512-7. PubMed ID: 12867592
[TBL] [Abstract][Full Text] [Related]
32. Agonists and antagonists of GnRH-I and -II reduce metastasis formation by triple-negative human breast cancer cells in vivo.
Schubert A; Hawighorst T; Emons G; Gründker C
Breast Cancer Res Treat; 2011 Dec; 130(3):783-90. PubMed ID: 21279682
[TBL] [Abstract][Full Text] [Related]
33. Immunocytochemical localisation of plasma membrane GHRH receptors in human tumours using a novel anti-peptide antibody.
Schulz S; Röcken C; Schulz S
Eur J Cancer; 2006 Sep; 42(14):2390-6. PubMed ID: 16904887
[TBL] [Abstract][Full Text] [Related]
34. Immunohistochemical detection of GHRH and its receptor splice variant 1 in primary human breast cancers.
Chatzistamou I; Schally AV; Kiaris H; Politi E; Varga J; Kanellis G; Kalofoutis A; Pafiti A; Koutselini H
Eur J Endocrinol; 2004 Sep; 151(3):391-6. PubMed ID: 15362970
[TBL] [Abstract][Full Text] [Related]
35. Differential immunostaining of various types of breast carcinomas for growth hormone-releasing hormone receptor - Apocrine epithelium and carcinomas emerging as uniformly positive.
Kővári B; Rusz O; Schally AV; Kahán Z; Cserni G
APMIS; 2014 Sep; 122(9):824-31. PubMed ID: 24479854
[TBL] [Abstract][Full Text] [Related]
36. Autocrine/paracrine regulation of breast cancer cell proliferation by growth hormone releasing hormone via Ras, Raf, and mitogen-activated protein kinase.
Siriwardana G; Bradford A; Coy D; Zeitler P
Mol Endocrinol; 2006 Sep; 20(9):2010-9. PubMed ID: 16613992
[TBL] [Abstract][Full Text] [Related]
37. Regulation of the pituitary growth hormone-releasing hormone receptor in ageing male and female LOU rats: new insights into healthy ageing.
Veyrat-Durebex C; Alliot J; Gaudreau P
J Neuroendocrinol; 2005 Nov; 17(11):691-700. PubMed ID: 16218997
[TBL] [Abstract][Full Text] [Related]
38. Extrapituitary effects of the growth hormone-releasing hormone.
Kiaris H; Schally AV; Kalofoutis A
Vitam Horm; 2005; 70():1-24. PubMed ID: 15727800
[TBL] [Abstract][Full Text] [Related]
39. Stimulatory effect of growth hormone-releasing hormone (GHRH(1-29)NH2) on the proliferation, VEGF and chromogranin A secretion by human neuroendocrine tumor cell line NCI-H727 in vitro.
Stepień T; Sacewicz M; Lawnicka H; Krupiński R; Komorowski J; Siejka A; Stepień H
Neuropeptides; 2009 Oct; 43(5):397-400. PubMed ID: 19747727
[TBL] [Abstract][Full Text] [Related]
40. Antagonists of growth hormone releasing hormone and bombesin inhibit the expression of EGF/HER receptor family in H-69 small cell lung carcinoma.
Kanashiro CA; Schally AV; Varga JL; Hammann B; Halmos G; Zarandi M
Cancer Lett; 2005 Aug; 226(2):123-31. PubMed ID: 16039952
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]